Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-26

Clinical Trial Update: The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial from Istanbul University evaluated whether preoperative ferric carboxymaltose reduces mortality in geriatric hip fracture patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Istanbul University | Conditions: Hip Fractures, Anemia | Phase 4 | Status: COMPLETED